CHMP recommends EU approval of Roche’s fixed-duration Columvi for large B-cell lymphoma
Once approved, Columvi will be the first CD20xCD3 T-cell-engaging bispecific antibody available to treat people in Europe with this aggressive lymphoma
Once approved, Columvi will be the first CD20xCD3 T-cell-engaging bispecific antibody available to treat people in Europe with this aggressive lymphoma
The policymakers, doctors and, patient bodies discuss ways to implement thalassemia control programme nationally
A special technique of jet injection is used to make vaccination almost painless and totally needleless.
The meeting provides recommendations to the G20 and its Member States and international partners on the establishment of a R&D and manufacturing network for diagnostics
mRNA-4157 (V940) in combination with KEYTRUDA reduced the risk of recurrence or death by 44% compared to KEYTRUDA alone in stage III/IV melanoma patients
Clinical Decision Support Systems' huge potential to help ensure that each patient can receive high-quality care; study shows a reduction in diagnostic errors from 24% to 2%
The company had acquired 26,000 equity shares having face value of Rs. 10 each fully paid up of Eqova
Envelta is the company’s non-opioid pain product candidate for acute and chronic pain
Getinge has a strong market share in India within several product segments
The facility is over 79,000 square feet and is equipped with packaging lines
Subscribe To Our Newsletter & Stay Updated